• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于重组髓鞘少突胶质细胞糖蛋白的免疫毒素对自身反应性B淋巴细胞的消耗

Depletion of autoreactive B-lymphocytes by a recombinant myelin oligodendrocyte glycoprotein-based immunotoxin.

作者信息

Nachreiner Thomas, Kampmeier Florian, Thepen Theo, Fischer Rainer, Barth Stefan, Stöcker Michael

机构信息

Fraunhofer IME, Department of Pharmaceutical Product Development, Forckenbeckstr. 6, D-52074 Aachen, Germany.

出版信息

J Neuroimmunol. 2008 Mar;195(1-2):28-35. doi: 10.1016/j.jneuroim.2008.01.001. Epub 2008 Feb 15.

DOI:10.1016/j.jneuroim.2008.01.001
PMID:18280586
Abstract

We report the construction of a fusion protein comprising the extracellular domain of myelin oligodendrocyte glycoprotein (MOG) and a truncated version of Pseudomonas aeruginosa exotoxin A (ETA'). The chimeric immunotoxin targeted MOG-reactive B-lymphocytes by binding selectively to the appropriate receptors, leading to internalization and apoptosis of the target cells. The functionality of the immunotoxin was tested on a MOG-sensitive murine hybridoma cell line and ex vivo on freshly isolated splenocytes from transgenic IgH(MOG) mice. These data demonstrate, for the first time, the specific cytotoxicity of a MOG-containing recombinant immunotoxin expressed in bacteria towards MOG-reactive B-lymphocytes.

摘要

我们报道了一种融合蛋白的构建,该融合蛋白包含髓鞘少突胶质细胞糖蛋白(MOG)的细胞外结构域和铜绿假单胞菌外毒素A(ETA')的截短形式。这种嵌合免疫毒素通过选择性地结合适当的受体靶向MOG反应性B淋巴细胞,导致靶细胞内化和凋亡。在MOG敏感的小鼠杂交瘤细胞系上以及在来自转基因IgH(MOG)小鼠的新鲜分离脾细胞上对免疫毒素的功能进行了体外测试。这些数据首次证明了在细菌中表达的含MOG重组免疫毒素对MOG反应性B淋巴细胞具有特异性细胞毒性。

相似文献

1
Depletion of autoreactive B-lymphocytes by a recombinant myelin oligodendrocyte glycoprotein-based immunotoxin.基于重组髓鞘少突胶质细胞糖蛋白的免疫毒素对自身反应性B淋巴细胞的消耗
J Neuroimmunol. 2008 Mar;195(1-2):28-35. doi: 10.1016/j.jneuroim.2008.01.001. Epub 2008 Feb 15.
2
T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice.源自HLA-DRB1*1501转基因小鼠的、对髓鞘少突胶质细胞糖蛋白35-55肽具有特异性的T细胞杂交瘤。
J Neurosci Res. 2004 Sep 1;77(5):670-80. doi: 10.1002/jnr.20201.
3
Specific depletion of autoreactive B lymphocytes by a recombinant fusion protein in vitro and in vivo.一种重组融合蛋白在体外和体内对自身反应性B淋巴细胞的特异性清除。
Int Immunol. 2003 Jul;15(7):789-96. doi: 10.1093/intimm/dxg076.
4
A bispecific single-chain antibody fusion protein for targeted depletion of autoreactive B cells via unstimulated human T lymphocytes.一种双特异性单链抗体融合蛋白,用于通过未受刺激的人T淋巴细胞靶向清除自身反应性B细胞。
Mol Immunol. 2004 Jul;41(5):511-8. doi: 10.1016/j.molimm.2004.04.002.
5
Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein.抗原特异性抗体在重组髓鞘少突胶质细胞糖蛋白诱导的实验性自身免疫性脑脊髓炎中的关键作用
Eur J Immunol. 2002 Jul;32(7):1905-13. doi: 10.1002/1521-4141(200207)32:7<1905::AID-IMMU1905>3.0.CO;2-L.
6
Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice.髓鞘/少突胶质细胞糖蛋白缺陷(MOG缺陷)小鼠显示野生型小鼠对MOG缺乏免疫耐受性。
J Clin Invest. 2003 Aug;112(4):544-53. doi: 10.1172/JCI15861.
7
Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice.髓鞘少突胶质细胞糖蛋白免疫显性区域内最小致脑炎性表位的描绘:识别对T细胞受体Vβb和T细胞受体Vβa H-2b小鼠具有致脑炎性的核心表位的T细胞对不同Vβ基因的使用情况
Eur J Immunol. 1996 Oct;26(10):2470-9. doi: 10.1002/eji.1830261030.
8
Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions.多发性硬化症中针对髓鞘少突胶质细胞糖蛋白(MOG)的自身免疫反应占主导:对MOG细胞外结构域的反应针对三个主要区域。
Eur J Immunol. 1997 Nov;27(11):3059-69. doi: 10.1002/eji.1830271144.
9
Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): prime role of MOG44F in selection and control of MOG-reactive T cells in H-2b mice.针对髓鞘少突胶质细胞糖蛋白(MOG)的T细胞自身免疫剖析:MOG44F在H-2b小鼠中对MOG反应性T细胞的选择和控制中的主要作用。
Eur J Immunol. 2006 Feb;36(2):478-93. doi: 10.1002/eji.200535363.
10
Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.髓鞘少突胶质细胞糖蛋白(MOG)衍生肽诱导PL/J小鼠发生的慢性复发性实验性自身免疫性脑脊髓炎,起病延迟且临床病程不典型:MOG T细胞表位的初步分析
Eur J Immunol. 1995 Apr;25(4):985-93. doi: 10.1002/eji.1830250419.

引用本文的文献

1
Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas.高 N-糖基化 SEL1L3 作为原发性玻璃体视网膜淋巴瘤的自身抗原 B 细胞受体靶点。
Sci Rep. 2024 Apr 26;14(1):9571. doi: 10.1038/s41598-024-60169-5.
2
Effect of Antigen Valency on Autoreactive B-Cell Targeting.抗原价态对自身反应性B细胞靶向的影响。
Mol Pharm. 2024 Feb 5;21(2):481-490. doi: 10.1021/acs.molpharmaceut.3c00527. Epub 2023 Oct 20.
3
A recombinant Der p 1-specific allergen-toxin demonstrates superior killing of allergen-reactive IgG hybridomas in comparison to its recombinant allergen-drug conjugate.
与重组变应原-药物偶联物相比,一种重组的特异性抗Der p 1变应原毒素对变应原反应性IgG杂交瘤具有更强的杀伤作用。
Immunother Adv. 2022 Dec 6;3(1):ltac023. doi: 10.1093/immadv/ltac023. eCollection 2023.
4
B-cell receptors of EBV-negative Burkitt lymphoma bind modified isoforms of autoantigens.EBV 阴性的伯基特淋巴瘤的 B 细胞受体结合自身抗原的修饰异构体。
EJHaem. 2022 Jun 16;3(3):739-747. doi: 10.1002/jha2.475. eCollection 2022 Aug.
5
Role of Specific B-Cell Receptor Antigens in Lymphomagenesis.特定B细胞受体抗原在淋巴瘤发生中的作用。
Front Oncol. 2020 Dec 9;10:604685. doi: 10.3389/fonc.2020.604685. eCollection 2020.
6
Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma.将B细胞受体抗原Neurabin-I/SAMD14整合到抗体形式中作为治疗原发性中枢神经系统淋巴瘤的新治疗方法。
Front Oncol. 2020 Nov 12;10:580364. doi: 10.3389/fonc.2020.580364. eCollection 2020.
7
Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphoma.鉴定非典型修饰的自身抗原Ars2为活化B细胞型弥漫性大B细胞淋巴瘤中B细胞受体的靶点。
Haematologica. 2021 Aug 1;106(8):2224-2232. doi: 10.3324/haematol.2019.241653.
8
The riddle of lymphoma BCR-antigenes.淋巴瘤BCR抗原之谜。
Oncotarget. 2018 Nov 9;9(88):35805-35806. doi: 10.18632/oncotarget.26318.
9
Sequential Prodrug Strategy To Target and Eliminate ACPA-Selective Autoreactive B Cells.序贯前药策略靶向和消除 ACPA 选择性自身反应性 B 细胞。
Mol Pharm. 2018 Dec 3;15(12):5565-5573. doi: 10.1021/acs.molpharmaceut.8b00741. Epub 2018 Oct 26.
10
Generation of an artificial human B cell line test system using Transpo-mAbTM technology to evaluate the therapeutic efficacy of novel antigen-specific fusion proteins.利用Transpo-mAbTM技术生成人工人B细胞系测试系统,以评估新型抗原特异性融合蛋白的治疗效果。
PLoS One. 2017 Jul 13;12(7):e0180305. doi: 10.1371/journal.pone.0180305. eCollection 2017.